Regeneron: FDA OKs Livsayis (cemdisiran) for treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody-positive, the predominant form of the disease $REGN, #RegeneronPharmaceuticals, #Regeneron crweworld.com/article/news-p…
21
Pyxis Oncology: Updated MICVO Phase 1 monotherapy data shows durable response in patients with second-line and beyond recurrent/metastatic head and neck squamous cell carcinoma (2L+ R/M HNSCC) $PYXS, #PyxisOncology, #Pyxis crweworld.com/article/news-p…
29
The Real Numbers Behind Palo Alto Networks Revealed $PANW, #PaloAltoNetworks, #PaloAlto crweworld.com/article/news-p…
46
Eloxx Pharmaceuticals: First-in-human evidence of exaluren-mediated readthrough of collagen IV in patients with nonsense mutation Alport syndrome $ELOX, #EloxxPharmaceuticals, #EloxxPharma, #Eloxx crweworld.com/article/news-p…
41
Biogen: New Three-Year Real-World LEQEMBI analysis includes findings on amyloid clearance in routine clinical practice, delayed progression to moderate or severe Alzheimer’s disease (AD), expanded subcutaneous maintenance experience $BIIB, #Biogen, #Eisai crweworld.com/article/news-p…
43
Sanofi: Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease $SNY, #Sanofi crweworld.com/article/news-p…
49
BillionToOne Responds to Inaccurate and Misleading Short Seller Report $BLLN, #BillionToOne crweworld.com/article/news-p…
73
InspireMD: First U.S. Commercial TCAR Procedures Using the FDA-Approved CGuard Prime TransCarotid Stent System $NSPR, #InspireMD crweworld.com/article/news-p…
37
Innoviz Reveals 1-for-20 Reverse Stock Split $INVZ, #InnovizTechnologies, #InnovizTech, #InnovizLiDAR, #Innoviz, #LiDAR crweworld.com/article/news-p…
90
WeTouch Technology’s Largest Shareholder Plans to Purchase at Least $1M Worth of WeTouch Common Stock in the Open Market in Light of the Company’s Current Market Valuatio $WETH, #WeTouchTechnology, #WeTouchTech, #WeTouch crweworld.com/article/news-p…
58
Phaos Technology: Unusual Market Activity - What You Need to Know $POAS, #PhaosTechnology, #PhaosTech, #Phaos crweworld.com/article/news-p…
46
KULR Secures New $14.8M Purchase Order for KULR ONE Max Energy Storage Systems $KULR, #KULRTechnology, #KULRTech crweworld.com/article/news-p…
57
NetClass Technology Reveals 1-for-10 Reverse Stock Split $NTCL, #NetClassTechnology, #NetClassTech, #NetClass crweworld.com/article/news-p…
62
Actuate Therapeutics: Daily oral elraglusib achieved up to 77% tumor growth inhibition as monotherapy in an aggressive preclinical melanoma model, with greater antitumor activity observed at higher drug exposures $ACTU, #ActuateTherapeutics, #ActuateTx crweworld.com/article/news-p…
62
Lichen International Reveals 1-for-100 Reverse Stock Split $LICN, #LichenInternational, #LichenIntl, #Lichen crweworld.com/article/news-p…
116
PACE Organization InnovAge Agrees to Pay $36M to Resolve False Claims Act Allegations of Failing to Provide Comprehensive Medical Services and Timely Specialist Referrals to Seniors $INNV, #InnovAgeHolding, #InnovAge crweworld.com/usa/trendingno…
44
